The US is doing more in the COVID-19 space than anywhere in the world due to the strength of its innovative ecosystem, says Michelle McMurry-Heath, president & CEO of life sciences advocacy group Biotechnology Innovation Organization (BIO). But such innovation is under threat due to “reckless” orders coming out of the White House.
As part of an exclusive interview filmed for Xconomy’s Xcelerate’s Keynote Series at Biotech Week Boston next week, McMurry-Heath (pictured above) criticized an executive order issued by President Trump on Sunday intended on lowering drug pricing.
“The executive orders that were issued this week by President Trump are... Read more »
Author: Dan Stanton
Date : 2020-09-17T14:31:13.000Z